Cited by — Clinical Outcomes of Ramucirumab Plus Taxane After Immune Checkpoint Inhibitor Therapy in HER2-negative Advanced Gastric Cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Clinical Outcomes of Ramucirumab Plus Taxane After Immune Checkpoint Inhibitor Therapy in HER2-negative Advanced Gastric Cancer.
No admitted local citation edges point to this work yet.
